Announced Mon, 20 Jul · 12:33 IST
Board meeting on 29 July 2026 to approve Q1 FY27 results
Results View source PDF
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+3.4%1-day move
₹179.24
prior close
₹178.15
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.2-0.3+0.6+3.4-1.2+0.8+1.1+7.1—————
Up moveDown movePending
AI summary
Piramal Pharma has informed BSE that its Board will meet on 29 July 2026 to consider and approve the unaudited standalone and consolidated financial results for Q1 FY27, quarter ended 30 June 2026. The trading window for dealing in company securities remains closed till 31 July 2026.
Likely market impact
Routine intimation ahead of Q1 results. No numbers yet; watch earnings on 29 July for revenue, margins, and profit trends.